Técnicas de Matriz oclusal versus Técnica Convencional na Restauração Direta com Resina composta em dentes posteriores - Um estudo in vitro

Várias ‘’stamp technique’’ (técnica de matriz oclusal) têm sido descritas como métodos simples para restaurar dentes cariados com topografia oclusal intacta, duplicando a anatomia oclusal quase na perfeição. A replicação da anatomia oclusal dos dentes posteriores durante a restauração direta com resinas compostas, apresenta elevada complexidade devido à existência de sulcos, fóssulas e fissuras, exigindo conhecimento anatómico e habilidade técnica para esculpir corretamente todos os detalhes da morfologia oclusal, a fim de devolver função, integridade estrutural e oclusão adequados. Do ponto de vista clínico a opção não é fácil, pois pouco está descrito com rigor quanto às eventuais vantagens técnicas, tempo dispendido ou até custos inerentes a qualquer uma das ‘’stamp technique’’. Com este estudo pretendeu-se responder as algumas destas questões. No final desta investigação, foi possível concluir que a técnica de matriz oclusal pode ser feita com diferentes materiais e que todas têm vantagens e inconvenientes. Esta técnica é uma alternativa à técnica convencional em casos específicos de restaurações com resina composta, em dentes posteriores. É um procedimento simples, facilmemente replicável e que devido à conservação da anatomia oclusal original, permite otimização do tempo clínico com redução de ajustes finais, sem comprometer a integridade marginal

Prévalence et facteurs associés aux lésions apicales d origine endodontique (analyse C.B.C.T.)

TOULOUSE3-BU Santé-Centrale (315552105) / SudocSudocFranceF

Prevalence of Apical Bone Defects and Evaluation of Associated Factors Detected with Cone-beam Computed Tomographic Images.

INTRODUCTION: Cone-beam computed tomographic (CBCT) imaging has been shown to be accurate for detecting apical bone defects (ABDs). Medium field of view CBCT imaging may provide apical images of the whole oral cavity at a resolution that is sufficient to allow ABDs to be located and measured. The aim of the work presented was to calculate the prevalence of ABDs from CBCT images as well as to assess some associated factors and their measurement. METHODS: One hundred CBCT data sets with a voxel size of 0.2 mm were analyzed by 2 evaluators according to a standardized reading protocol. The number of maxillary and mandibular teeth, the presence of endodontic treatment, and the presence of ABDs associated with endodontic treatment were identified, and the presence of intraradicular posts was documented. The size of ABDs detected was measured, and they were classified according to the Cone Beam Computed Tomography Periapical Index. RESULTS: A total of 2368 teeth and 100 subjects were analyzed. The prevalence of ABDs in subjects was 78%; in 8.6% of the sample teeth, ABDs were present, and 38.2% of endodontically treated maxillary molars were affected by it. Endodontic treatment was significantly associated with an increased risk for the presence of an ABD (P = .0001); 40.8% of endodontically treated teeth were associated with an ABD. This rate increased to 85.9% in endodontically treated maxillary molars. Placement of a post was significantly associated with the presence of an ABD (P = .003). The most frequent lesions were those with diameters between 2 and 4 mm (39.2%). CONCLUSIONS: There are only few studies on the prevalence of ABDs using CBCT analysis. This study in a French population shows a high prevalence of ABDs, especially on endodontically treated molars. The most effective way to exhaustively detect such defects is with CBCT imaging. Moreover, CBCT images show details of the extent of bone loss, thus providing information valuable for the therapeutic decision and details that could help with the prognosis

Definitions and Epidemiology of Endodontic Infections

Purpose of Review: This review describes the recent findings from epidemiological studies on endodontic infections. The recent literature was screened for studies on the prevalence of primary apical periodontitis and posttreatment apical periodontitis in various populations. Recent Findings: Twenty-nine articles reporting data on the prevalence of primary or posttreatment apical periodontitis from all over the world were included. The prevalence of apical periodontitis varied between 7 and 86%, while that of posttreatment apical periodontitis varied between 10 and 62%. The quality of the coronal restoration and the root filling appears to be the major predictors of apical periodontitis. Summary: The recent findings from epidemiological studies on the prevalence of primary and posttreatment apical periodontitis in various populations are not substantially different from those from earlier years. It appears that the health of periapical tissues has not majorly improved in the general population

Prevalence of Apical Periodontitis and Conventional Nonsurgical Root Canal Treatment in General Adult Population: An Updated Systematic Review and Meta-analysis of Cross-sectional Studies Published between 2012 and 2020

Introduction This study aimed to summarize data on apical periodontitis (AP) and nonsurgical root canal treatment (NSRCT) prevalence and risk factors related to age, gender, and quality of restorative and endodontic treatment in the general population from cross-sectional studies published between 2012 and 2020. Methods An electronic search was performed in the following databases: Web of Science, Scopus, and PubMed. The conducted literature search covered studies published between 2012 and 2020, without restrictions on language. The STROBE and NOS tools were used for quality assessment of the included studies. Results Sixteen articles were included in the review. In total, 200,041 teeth were examined. On average, 6.3% of teeth had AP, and 7.4% had NSRCT. Forty-one percent of RCT teeth had AP, and 3.5% of untreated teeth had AP. Female patients were less prone to AP in endodontically treated teeth only, compared with male patients (P < .001). Variable stratification of age subgroups among included studies prevented us from conducting a meta-analysis. An increase in AP frequency was found in teeth with inadequate restorative and endodontic treatment (P < .001 and P < .001, respectively). Because of high heterogeneity, these results should be taken with caution. Conclusions There is an increased AP prevalence in the adult general population compared with data from 2012 (6.3% versus 5.4%) in both endodontically treated (41.3% versus 35.9%) and untreated teeth (3.5% versus 2.1%). In addition, AP developed less frequently in female patients with endodontically treated teeth and in teeth with inadequate compared with adequate restorative and endodontic treatment.This is the peer-reviewed version of the article: Jakovljevic A, Nikolic N, Jacimovic J, Pavlovic O, Milicic B, Beljic-Ivanovic K, Miletic M, Andric M, Milasin J. Prevalence of Apical Periodontitis and Conventional Nonsurgical Root Canal Treatment in General Adult Population: An Updated Systematic Review and Meta-analysis of Cross-sectional Studies Published between 2012–2020. Journal of Endodontics. 2020;46(10):1371-1386.e8. [https://doi.org/10.1016/j.joen.2020.07.007

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

International audienc

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

International audienc

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

International audienceImportance Severe pneumonia with hyperinflammation and elevated interleukin-6 is a common presentation of coronavirus disease 2019 (COVID-19).Objective To determine whether tocilizumab (TCZ) improves outcomes of patients hospitalized with moderate-to-severe COVID-19 pneumonia.Design, Setting, and Particpants This cohort-embedded, investigator-initiated, multicenter, open-label, bayesian randomized clinical trial investigating patients with COVID-19 and moderate or severe pneumonia requiring at least 3 L/min of oxygen but without ventilation or admission to the intensive care unit was conducted between March 31, 2020, to April 18, 2020, with follow-up through 28 days. Patients were recruited from 9 university hospitals in France. Analyses were performed on an intention-to-treat basis with no correction for multiplicity for secondary outcomes.Interventions Patients were randomly assigned to receive TCZ, 8 mg/kg, intravenously plus usual care on day 1 and on day 3 if clinically indicated (TCZ group) or to receive usual care alone (UC group). Usual care included antibiotic agents, antiviral agents, corticosteroids, vasopressor support, and anticoagulants.Main Outcomes and Measures Primary outcomes were scores higher than 5 on the World Health Organization 10-point Clinical Progression Scale (WHO-CPS) on day 4 and survival without need of ventilation (including noninvasive ventilation) at day 14. Secondary outcomes were clinical status assessed with the WHO-CPS scores at day 7 and day 14, overall survival, time to discharge, time to oxygen supply independency, biological factors such as C-reactive protein level, and adverse events.Results Of 131 patients, 64 patients were randomly assigned to the TCZ group and 67 to UC group; 1 patient in the TCZ group withdrew consent and was not included in the analysis. Of the 130 patients, 42 were women (32%), and median (interquartile range) age was 64 (57.1-74.3) years. In the TCZ group, 12 patients had a WHO-CPS score greater than 5 at day 4 vs 19 in the UC group (median posterior absolute risk difference [ARD] −9.0%; 90% credible interval [CrI], −21.0 to 3.1), with a posterior probability of negative ARD of 89.0% not achieving the 95% predefined efficacy threshold. At day 14, 12% (95% CI −28% to 4%) fewer patients needed noninvasive ventilation (NIV) or mechanical ventilation (MV) or died in the TCZ group than in the UC group (24% vs 36%, median posterior hazard ratio [HR] 0.58; 90% CrI, 0.33-1.00), with a posterior probability of HR less than 1 of 95.0%, achieving the predefined efficacy threshold. The HR for MV or death was 0.58 (90% CrI, 0.30 to 1.09). At day 28, 7 patients had died in the TCZ group and 8 in the UC group (adjusted HR, 0.92; 95% CI 0.33-2.53). Serious adverse events occurred in 20 (32%) patients in the TCZ group and 29 (43%) in the UC group (P = .21).Conclusions and Relevance In this randomized clinical trial of patients with COVID-19 and pneumonia requiring oxygen support but not admitted to the intensive care unit, TCZ did not reduce WHO-CPS scores lower than 5 at day 4 but might have reduced the risk of NIV, MV, or death by day 14. No difference on day 28 mortality was found. Further studies are necessary for confirming these preliminary results.Trial Registration ClinicalTrials.gov Identifier: NCT0433180